138 related articles for article (PubMed ID: 38924612)
41. Exploration of quantitative site-specific serum O-glycoproteomics with isobaric labeling for the discovery of putative O-glycoprotein biomarkers.
Zhang Z; Xu H; Tian Z
Proteomics Clin Appl; 2022 Nov; 16(6):e2100095. PubMed ID: 35507764
[TBL] [Abstract][Full Text] [Related]
42. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.
Pan J; Hu Y; Sun S; Chen L; Schnaubelt M; Clark D; Ao M; Zhang Z; Chan D; Qian J; Zhang H
Nat Commun; 2020 Dec; 11(1):6139. PubMed ID: 33262351
[TBL] [Abstract][Full Text] [Related]
43. GproDIA enables data-independent acquisition glycoproteomics with comprehensive statistical control.
Yang Y; Yan G; Kong S; Wu M; Yang P; Cao W; Qiao L
Nat Commun; 2021 Oct; 12(1):6073. PubMed ID: 34663801
[TBL] [Abstract][Full Text] [Related]
44. Global O-glycoproteome enrichment and analysis enabled by a combinatorial enzymatic workflow.
Kang T; Budhraja R; Kim J; Joshi N; Garapati K; Pandey A
Cell Rep Methods; 2024 Apr; 4(4):100744. PubMed ID: 38582075
[TBL] [Abstract][Full Text] [Related]
45. Site-Specific N- and O-Glycopeptide Analysis Using an Integrated C18-PGC-LC-ESI-QTOF-MS/MS Approach.
Stavenhagen K; Hinneburg H; Kolarich D; Wuhrer M
Methods Mol Biol; 2017; 1503():109-119. PubMed ID: 27743362
[TBL] [Abstract][Full Text] [Related]
46. Fast and comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco.
Polasky DA; Yu F; Teo GC; Nesvizhskii AI
Nat Methods; 2020 Nov; 17(11):1125-1132. PubMed ID: 33020657
[TBL] [Abstract][Full Text] [Related]
47. Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD.
Halim A; Nilsson J; Rüetschi U; Hesse C; Larson G
Mol Cell Proteomics; 2012 Apr; 11(4):M111.013649. PubMed ID: 22171320
[TBL] [Abstract][Full Text] [Related]
48. Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis.
Woo CM; Iavarone AT; Spiciarich DR; Palaniappan KK; Bertozzi CR
Nat Methods; 2015 Jun; 12(6):561-7. PubMed ID: 25894945
[TBL] [Abstract][Full Text] [Related]
49. Analysis of glycoprotein-derived glycopeptides.
Gerwig GJ; Vliegenthart JF
EXS; 2000; 88():159-86. PubMed ID: 10803378
[TBL] [Abstract][Full Text] [Related]
50. A Comprehensive, Open-source Platform for Mass Spectrometry-based Glycoproteomics Data Analysis.
Liu G; Cheng K; Lo CY; Li J; Qu J; Neelamegham S
Mol Cell Proteomics; 2017 Nov; 16(11):2032-2047. PubMed ID: 28887379
[TBL] [Abstract][Full Text] [Related]
51. N-glycoproteomics - an automated workflow approach.
Joenväärä S; Ritamo I; Peltoniemi H; Renkonen R
Glycobiology; 2008 Apr; 18(4):339-49. PubMed ID: 18272656
[TBL] [Abstract][Full Text] [Related]
52. Intact glycopeptide characterization using mass spectrometry.
Cao L; Qu Y; Zhang Z; Wang Z; Prytkova I; Wu S
Expert Rev Proteomics; 2016 May; 13(5):513-22. PubMed ID: 27140194
[TBL] [Abstract][Full Text] [Related]
53. Comparative glycoproteomics study on the surface of SKOV3
Zhou Y; Cai X; Wu L; Lin N
Front Chem; 2022; 10():1010642. PubMed ID: 36482940
[No Abstract] [Full Text] [Related]
54. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides.
Stavenhagen K; Hinneburg H; Thaysen-Andersen M; Hartmann L; Varón Silva D; Fuchser J; Kaspar S; Rapp E; Seeberger PH; Kolarich D
J Mass Spectrom; 2013 Jun; 48(6):627-39. PubMed ID: 23722953
[TBL] [Abstract][Full Text] [Related]
55. Glycomics-Assisted Glycoproteomics Enables Deep and Unbiased N-Glycoproteome Profiling of Complex Biological Specimens.
Chau TH; Chernykh A; Ugonotti J; Parker BL; Kawahara R; Thaysen-Andersen M
Methods Mol Biol; 2023; 2628():235-263. PubMed ID: 36781790
[TBL] [Abstract][Full Text] [Related]
56. Profiling Serum Intact N-Glycopeptides Using Data-Independent Acquisition Mass Spectrometry.
Yang Y; Qiao L
Methods Mol Biol; 2023; 2628():365-391. PubMed ID: 36781798
[TBL] [Abstract][Full Text] [Related]
57. An integrated strategy for high-sensitive and multi-level glycoproteome analysis from low micrograms of protein samples.
Gao W; Li H; Liu L; Huang P; Wang Z; Chen W; Ye M; Yu X; Tian R
J Chromatogr A; 2019 Aug; 1600():46-54. PubMed ID: 31036360
[TBL] [Abstract][Full Text] [Related]
58. Identification and characterization of intact glycopeptides in human urine.
Garcia-Marques F; Fuller K; Bermudez A; Shamsher N; Zhao H; Brooks JD; Flory MR; Pitteri SJ
Sci Rep; 2024 Feb; 14(1):3716. PubMed ID: 38355753
[TBL] [Abstract][Full Text] [Related]
59. An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptides.
Chen M; Shi X; Duke RM; Ruse CI; Dai N; Taron CH; Samuelson JC
Nat Commun; 2017 May; 8():15487. PubMed ID: 28534482
[TBL] [Abstract][Full Text] [Related]
60. Systems-Wide Site-Specific Analysis of Glycoproteins.
Alagesan K; Charpentier E
Methods Mol Biol; 2023; 2718():151-165. PubMed ID: 37665459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
